Know Cancer

or
forgot password

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening


Phase 3
18 Years
N/A
Not Enrolling
Both
Adrenal Gland Diseases, Adrenal Gland Neoplasms

Thank you

Trial Information

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

Inclusion Criteria


Adults with suspected adrenal disease, such as adrenal adenoma, carcinoma, hyperplasia, or
Addison's Disease.

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Principal Investigator

Donald A. Podoloff, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Food and Drug Administration

Study ID:

NUM88-001

NCT ID:

NCT00037843

Start Date:

December 1988

Completion Date:

August 2007

Related Keywords:

  • Adrenal Gland Diseases
  • Adrenal Gland Neoplasms
  • adrenal diseases
  • Adrenal Gland Diseases
  • Adrenal Gland Neoplasms
  • Neoplasms

Name

Location

University of Texas M.D. Anderson Cancer CenterHouston, Texas  77030